Thumbnail for Plexium
2 known investors
Plexium is a targeted protein degradation company developing small molecule therapeutics for treating diseases with high unmet medical needs using their proprietary DELTA Discovery platform.
Founders & leadership
MM
Michael Martin, Ph.D.Chief Executive Officer, President
MG
Mike GreyExecutive Chairman
JF
Jorge F. DiMartino
MM
Michael MartinPresident, Chief Executive Officer